Experience
CSL Behring
Finnegan represented CSL Behring in an ex parte reexamination and corresponding arbitration proceeding against Baxter and Bayer relating to Factor VIII blood products, securing a favorable settlement for our client.
CSL Behring GmbH v. Shire ViroPharma Inc.
CSL Behring GmbH
Shire ViroPharma Inc. v. CSL Behring LLC
CSL Behring LLC
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals v. Mylan
Cumberland Pharmaceuticals Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.